Aurora Cannabis Inc. (TSE:ACB – Get Free Report) shares reached a new 52-week low on Tuesday . The company traded as low as C$3.75 and last traded at C$3.84, with a volume of 284792 shares changing hands. The stock had previously closed at C$3.87.
Analysts Set New Price Targets
A number of equities analysts have weighed in on the stock. Canaccord Genuity Group reduced their price objective on shares of Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating for the company in a research report on Tuesday, June 30th. TD reduced their price objective on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of C$7.17.
Check Out Our Latest Report on ACB
Aurora Cannabis Stock Performance
Aurora Cannabis (TSE:ACB – Get Free Report) last announced its quarterly earnings results on Thursday, June 11th. The company reported C($0.99) EPS for the quarter. The firm had revenue of C$38.01 million for the quarter. Aurora Cannabis had a negative return on equity of 7.25% and a negative net margin of 12.13%. On average, analysts forecast that Aurora Cannabis Inc. will post -0.22 EPS for the current year.
Aurora Cannabis Company Profile
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
See Also
- Five stocks we like better than Aurora Cannabis
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
- Abivax: Wall Street Catches Up to the Data
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
